<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2018-4-3-0-2</article-id><article-id pub-id-type="publisher-id">1503</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>MOLECULAR-GENETIC ANALYSIS OF ASSOCIATIONS OF POLYMORPHOUS GENES COMBINATIONS OF THE XENOBIOTICS BIOTRANSFORMATION WITH THE ISOLATED VENTRICULAR SEPTAL DEFECT DEVELOPMENT IN THE KRASNODAR TERRITORY</article-title><trans-title-group xml:lang="en"><trans-title>MOLECULAR-GENETIC ANALYSIS OF ASSOCIATIONS OF POLYMORPHOUS GENES COMBINATIONS OF THE XENOBIOTICS BIOTRANSFORMATION WITH THE ISOLATED VENTRICULAR SEPTAL DEFECT DEVELOPMENT IN THE KRASNODAR TERRITORY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Lazarev</surname><given-names>Konstantin Yu.</given-names></name><name xml:lang="en"><surname>Lazarev</surname><given-names>Konstantin Yu.</given-names></name></name-alternatives><email>lazarev_ku@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Braiko</surname><given-names>Olga P.</given-names></name><name xml:lang="en"><surname>Braiko</surname><given-names>Olga P.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2018</year></pub-date><volume>4</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2018/3/ilovepdf_com-19-28.pdf" /><abstract xml:lang="ru"><p>Background: The study of the involvement of polymorphisms of candidate genes of the biotransformation system of xenobiotics in the formation of congenital malformations in children is one of the urgent problems of modern medicine. The aim of the study: To estimate the polymorphous genes associations of the xenobiotic biotransformation system with ventricular septal defect predilection in children in Krasnodar region. Materials and methods: Children with verified VSD (100 participants), mean age 3.11+0.85, were tested in the research,. The parents (without congenital minimum effective temperature) of children with VSD were tested as a population group. The participants were the innates of the Krasnodar Territory and belonged to the Slavic nationality. The DNA and polymorphous genes amplification were made in the real time mode; the derived genotypes were analysed by the alleles&amp;rsquo; discrimination method. The x2 criterion, for concordance estimation genotypes distribution of expected meanings by Hardy- Weinberg equilibrium and for the comparison of frequency genotypes and alleles distribution (among healthy and diseased patients), were used. Results: The statistical validity (having high risk of VSD formation) of 5 genotypes combinations was revealed: CYP1B 1432AA x NAT2&amp;nbsp;590GG, CYP1B1&amp;nbsp;432GG x CYP03A4&amp;nbsp;664TT, CYP3A4&amp;nbsp;664TT x CYP3A5 6986AA &amp;ndash; male gender, CYP1B1&amp;nbsp;432AG x NAT2&amp;nbsp;590AA, CYP2C9 1075AC x CYP3A4&amp;nbsp;664TC &amp;ndash; female gender, with indices (р&amp;lt;0.05, OR=3.29, 95% CI=1.11-9.74), (р&amp;lt;0.05, OR=14.23, 95% CI=1.72-117.86), (р&amp;lt;0.05, OR=4.75, 95% CI=0.98-23.10), (р&amp;lt;0.05, OR=2.66, 95% CI=0.95-7.41), (р&amp;lt;0.05, OR=7.07, 95% CI=0.77-64.83), including 3 combinations of protective character NAT2 590GA х ABCB1 3435CT (р&amp;lt;0.05, OR=0.37, 95% CI=0.15-0.94), CYP1B1 432АА х CYP2C9 1075AA (р&amp;lt;0.05, OR=0.40, 95% CI=0.17-1.00) &amp;ndash; male gender, CYP2C9 1075AC х CYP3A56986AA (р&amp;lt;0.05, OR=0.36, 95% CI=0.13-1.03) &amp;ndash; female gender. Conclusion: Eight pairs of combinations of genotypes of xenobiotic biotransformation enzymes associated with the risk of developing an isolated defect of the interventricular septum were established.</p></abstract><trans-abstract xml:lang="en"><p>Background: The study of the involvement of polymorphisms of candidate genes of the biotransformation system of xenobiotics in the formation of congenital malformations in children is one of the urgent problems of modern medicine. The aim of the study: To estimate the polymorphous genes associations of the xenobiotic biotransformation system with ventricular septal defect predilection in children in Krasnodar region. Materials and methods: Children with verified VSD (100 participants), mean age 3.11+0.85, were tested in the research,. The parents (without congenital minimum effective temperature) of children with VSD were tested as a population group. The participants were the innates of the Krasnodar Territory and belonged to the Slavic nationality. The DNA and polymorphous genes amplification were made in the real time mode; the derived genotypes were analysed by the alleles&amp;rsquo; discrimination method. The x2 criterion, for concordance estimation genotypes distribution of expected meanings by Hardy- Weinberg equilibrium and for the comparison of frequency genotypes and alleles distribution (among healthy and diseased patients), were used. Results: The statistical validity (having high risk of VSD formation) of 5 genotypes combinations was revealed: CYP1B 1432AA x NAT2&amp;nbsp;590GG, CYP1B1&amp;nbsp;432GG x CYP03A4&amp;nbsp;664TT, CYP3A4&amp;nbsp;664TT x CYP3A5 6986AA &amp;ndash; male gender, CYP1B1&amp;nbsp;432AG x NAT2&amp;nbsp;590AA, CYP2C9 1075AC x CYP3A4&amp;nbsp;664TC &amp;ndash; female gender, with indices (р&amp;lt;0.05, OR=3.29, 95% CI=1.11-9.74), (р&amp;lt;0.05, OR=14.23, 95% CI=1.72-117.86), (р&amp;lt;0.05, OR=4.75, 95% CI=0.98-23.10), (р&amp;lt;0.05, OR=2.66, 95% CI=0.95-7.41), (р&amp;lt;0.05, OR=7.07, 95% CI=0.77-64.83), including 3 combinations of protective character NAT2 590GA х ABCB1 3435CT (р&amp;lt;0.05, OR=0.37, 95% CI=0.15-0.94), CYP1B1 432АА х CYP2C9 1075AA (р&amp;lt;0.05, OR=0.40, 95% CI=0.17-1.00) &amp;ndash; male gender, CYP2C9 1075AC х CYP3A56986AA (р&amp;lt;0.05, OR=0.36, 95% CI=0.13-1.03) &amp;ndash; female gender. Conclusion: Eight pairs of combinations of genotypes of xenobiotic biotransformation enzymes associated with the risk of developing an isolated defect of the interventricular septum were established.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>congenital ventricular septal defect (VSD)</kwd><kwd>enzymes of xenobiotics biotransformation (EXB)</kwd><kwd>polymorphism</kwd><kwd>predilection marker</kwd><kwd>Krasnodar region</kwd></kwd-group><kwd-group xml:lang="en"><kwd>congenital ventricular septal defect (VSD)</kwd><kwd>enzymes of xenobiotics biotransformation (EXB)</kwd><kwd>polymorphism</kwd><kwd>predilection marker</kwd><kwd>Krasnodar region</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Bogacheva EV, Antonov OV, Artyukova SI, et al. [Congenital heart diseases: prevalence in the population, risk factors]. Mat&amp;#39; i ditya v Kuzbasse. 2012;1:19-24. Russian.</mixed-citation></ref><ref id="B2"><mixed-citation>Demikova NS, Lapina AS, Podol&amp;#39;naya MA, et al. [The dynamics of the frequency of congenital malformations in the Russian Federation (according to the data of the Federal Monitoring Base of the VPR for 2006-2012)]. Rossiyskiy vestnik perinatologii i pediatrii. 2015;2:72-77. Russian.</mixed-citation></ref><ref id="B3"><mixed-citation>Shabaldin AV, Glebova LA, Bachina AV, et al. [Peculiarities of epidemiology of congenital heart disease in children of Kemerovo as a large industrial center]. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy. 2014;(4):38-46. Russian.</mixed-citation></ref><ref id="B4"><mixed-citation>Bokeriya LA, Stupakov IN, Gudkova RG, et al. [Congenital anomalies (defects) of the circulatory system in the Russian population and their surgical treatment (2005-2014)]. Grudnaya i serdechno-sosudistaya khirurgiya. 2016;4:202-206. Russian.</mixed-citation></ref><ref id="B5"><mixed-citation>Lazarev KYu, Golubtsov VI. [Analysis of the structure and prevalence of isolated congenital malformations of the circulatory system among infants of the Krasnodar Territory (based on monitoring results of 1998-2009)]. Kubanskiy nauchnyy meditsinskiy vestnik. 2010;2(125):95-100. Russian.</mixed-citation></ref><ref id="B6"><mixed-citation>Shabaldin AV, Tsepokina AV, Shmulevich SA, et al. [Influence of social, medical and environmental factors on the formation of sporadic congenital heart defects]. Rossiyskiy vestnik perinatologii i pediatrii. 2018;63(1):14-21. Russian.</mixed-citation></ref><ref id="B7"><mixed-citation>Azarova I, Bushueva O, Konoplya A, et al. Glutathione S-transferase genes and the risk of type 2 diabetes mellitus: Role of sexual dimorphism, gene-gene and gene-smoking interactions in disease susceptibility. J Diabetes. 2018 May;10(5):398-407. doi: 10.1111/1753-0407.12623.</mixed-citation></ref><ref id="B8"><mixed-citation>Robert AM. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundamental and clinical pharmacology. 2007;21(4):427-435.</mixed-citation></ref><ref id="B9"><mixed-citation>Saab YB, Robert AM, Langaee T. Genetic Polymorphisms of CYP2C9: Comparison of Prevalence in the Lebanese Population with Other Populations. Pharmacology &amp;amp; Pharmacy. 2011;2:88-93.</mixed-citation></ref><ref id="B10"><mixed-citation>Polonikov A, Bykanova M, Ponomarenko I, et al. The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population. Clin Exp Hypertens. 2017;39(4):306-311. doi: 10.1080/10641963.2016.1246562.</mixed-citation></ref><ref id="B11"><mixed-citation>Haiyan J. &amp;nbsp;Biomarker insights. 2010;5:21-27.</mixed-citation></ref><ref id="B12"><mixed-citation>Sirotina S, Ponomarenko I, Kharchenko A, et al. A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease. Dis Markers. 2018 Feb 1;2018:5812802. doi: 10.1155/2018/5812802.</mixed-citation></ref><ref id="B13"><mixed-citation>Polonikov A, Kharchenko A, Bykanova M, et al. Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population. Gene. 2017 Sep 5;627:451-459. doi: 10.1016/j.gene.2017.07.004.</mixed-citation></ref><ref id="B14"><mixed-citation>Cotoa,e E. Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy. Biochemical and biophysical research communications. 2010;397(3):576-579.</mixed-citation></ref><ref id="B15"><mixed-citation>JG. The distribution of allelic and genotypic frequencies of N-Acetyltransferase-2 variants in an Argentine population. J infect dev ctries. 2012;6(9):671-674.</mixed-citation></ref><ref id="B16"><mixed-citation>Rebrova OYu. [Statistical analysis of medical data. Application of the STATISTICA software package]. M.: Media Sfera; 2002. Russian.</mixed-citation></ref></ref-list></back></article>